Health Care • Industrial Specialties
$5.55 ▲ +0.07
(+1.28%)
MKT CAP: $56.6M • VOL: 8.1K
52W L $4 52W H $8
APT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $59.1M | $57.8M | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | $22.5M | $22.9M | — |
| Gross Margin % | 38.1% | 39.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $3.8M | $3.4M | $4.1M |
| Operating Margin % | 6.5% | 6.0% | — |
| Net Income (GAAP) | $3.5M | $3.9M | $4.2M |
| EBITDA (Normalized) | $4.4M | $6.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.4M | $5.7M | $8.5M |
| Capital Expenditures (CapEx) | $639.0K | $3.8M | — |
| Free Cash Flow (FCF) | $1.7M | $1.9M | $8.5M |
| FCF Margin % | 2.9% | 3.3% | — |
| Return on Invested Capital (ROIC %) | 6.7% | 6.2% | — |
| Cash & Short-Term Equivalents | $17.0M | $18.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $62.5M | $62.2M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR APT.